FUJIFILM Fiscal Year 2020: Imaging Division Suffers COVID-19, Operating Income Down 51%, Revenue Down 14%, Strong GFX100/X100V/X-Pro3 Sales

Fujifilm has now published its fiscal report for the fiscal year 2020 (1 April 2019 – 31 March 2020).

Fellow FR-reader Mistral has summarized it in French over at the French forum chassimages. In short:

Fujifilm as a whole is still doing well even if it has not reached the expected goals given the impact of the Covid-19 epidemic on its last quarter.

Imaging Solutions is the division with the lowest performance.

Fujifilm records a loss in the last quarter. The decline in sales of digital cameras and their lenses has accelerated throughout the year.

The only positive note: the Fujifilm GFX100 keeps up selling strong, as well as the Fujifilm X100V and Fujifilm X-Pro3 are mentioned positively in the various reports.

Fujifilm Report (Imaging Solution)

** CLICK HERE to Read the Rest of the Article **

Notification of Application of Public Medical Insurance to the New Gene Detection Kit “SARS-CoV-2 RT-qPCR Detection kit” for Coronavirus that Greatly shortens PCR Test Time

We reported on April 3, how Fujifilm was developing a fast test for Coronovirus. Here are the latest updates form Fujifilm.

Notification of application of public medical insurance to the new gene detection kit “SARS-CoV-2 RT-qPCR Detection kit” for coronavirus that greatly shortens PCR test time (Fujifilm Wako Pure Chemical)

translated from Japanese

May 1, 2020 FUJIFILM Wako Pure Chemical Industries, Ltd.

** CLICK HERE to Read the Rest of the Article **

FUJIFILM Teams Up with Bill Gates’ Therapeutics Accelerator Foundation to Battle COVID-19

Fujifilm continues to work on solutions for the COVID-19 pandemic. This time they announced they have teamed up with “COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies“.

The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation to speed-up the response to the global pandemic.

FujiRumors is on Patreon, Facebook, Instagram, RSS-feed, Youtube, Flipboard and Twitter

FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies

** CLICK HERE to Read the Rest of the Article **

FUJIFILM Postpones Announcement of Financial Results for the Fiscal Year 2020 due to COVID-19

Fujifilm just announced the postponement of the release of the financial results for the fiscal year ended March 31, 2020*. They need more time to make the report due to COVID-19.

They anticipate the inevitable: COVID-19 had a big impact on “some products“, and you can be sure cameras are one of those products.

The impact of COVID-19 is also seen on sales of some products and services. The effect on the performance for the fiscal year ended March 31, 2020 is currently under review and shall be notified as soon as we identified matters requiring disclosure

Overall, though, Fujifilm is in a better position than Nikon for example, as Fujifilm is a very diversified company. Down below you can see the yearly stock performance of Fujifilm, Nikon, Canon and Sony.

Also Nikon and other companies have postponed the fiscal year results announcement.

* the Japanese fiscal year 2020 started on the 1st of April 2019 and ended on the 31th of March 2020.

Our Owners Groups

Our Facebook Pages

Press Release

** CLICK HERE to Read the Rest of the Article **